Baron Funds, an investment management company, released its “Baron Health Care Fund” second-quarter 2025 investor letter. A ...

Thermo Fisher shows signs of post-COVID recovery, but modest growth, valuation risks, and macro pressures warrant caution.

Employed biopharma professionals are highly likely to look for new jobs in the next 12 months, although not quite as likely ...

Discover how the biopharmaceutical industry is embracing AI in a practical and effective way by focusing on readiness and implementation strategies for 2025.

See the latest Thermo Fisher Scientific Inc stock price (TMO:XNYS), related news, valuation, dividends and more to help you make your investing decisions.

The report "Chromatography Resin Market by Type (Natural, Synthetic, Inorganic Media), Technique ((Ion Exchange (Cation and ...

Feeling strapped for cash? Select outlines ways you can find or redeem unclaimed money that's yours, whether it was lost or forgotten.

For example, 2024’s biopharma IPO market began promisingly with $3.6 billion in total funding in Q1 – the highest in several years – but fell to $1.6 billion across Q2 and Q3 combined, as ...

Against steep odds and well-established paradigms, these four companies have successfully been commercializing their products ...

Discover real-time Vor Biopharma Inc. Common Stock (VOR) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq.